Research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) develops drug shown to extend survival time for patients with glioblastoma, the most common primary brain tumor in adults. SAN ANTONIO, Texas, March 7, 2025 /PRNewswire-PRWeb/ — A drug…